IGM BIOSCIENCES INC (IGMS)

US4495851085 - Common Stock

6.8  +0.3 (+4.62%)

After market: 6.8 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
1.07M2.13M
99.07%
2.632M
23.57%
7.695M
192.36%
13.056M
69.67%
20.881M
59.93%
56.55M
170.82%
157.12M
177.84%
427.6M
172.15%
685.61M
60.34%
EBITDA
YoY % growth
-160.84M
-95.55%
-221.88M
-37.95%
-255.184M
-15.01%
-216.883M
15.01%
-171.33M
21.00%
-188.817M
-10.21%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-165.32M
-98.51%
-227.96M
-37.89%
-263.461M
-15.57%
-222.304M
15.62%
-163.929M
26.26%
-173.43M
-5.80%
-190.769M
-10.00%
-183.271M
3.93%
-132.009M
27.97%
67.436M
151.08%
278.1M
312.39%
Operating Margin
N/A-21,304.67%-12,369.06%-8,446.18%-2,130.34%-1,328.35%-913.60%-324.09%-84.02%15.77%40.56%
EPS
YoY % growth
-4.93
-86.04%
-5.37
-8.92%
-4.81
10.43%
-3.41
29.10%
-2.31
32.30%
-2.06
10.97%
-2.33
-13.40%
-1.58
32.17%
-0.61
61.61%
0.71
217.65%
2.31
222.86%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.77
23.37%
-0.53
36.51%
-0.38
51.80%
-0.34
66.67%
-0.30
61.34%
-0.37
28.97%
-0.37
3.84%
-0.39
-17.27%
-0.42
-39.09%
Revenue
Q2Q % growth
313.283K
-51.88%
3.417M
587.53%
3.417M
172.49%
3.417M
562.21%
3.417M
990.71%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
-47.619M
16.23%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-49.852M
23.45%
-40.086M
25.57%
-30.906M
39.82%
-20.196M
59.93%
-11.526M
76.88%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-1.01
2.88%
-0.82-0.19-23.77%
Q2 2024
Q2Q % growth
-0.79
44.76%
-0.04-0.75-1,950.05%
Q1 2024
Q2Q % growth
-0.83
37.59%
-0.850.022.12%
Q4 2023
Q2Q % growth
-1.01
15.13%
-1.050.044.11%
Q3 2023
Q2Q % growth
-1.04
21.21%
-1.240.2015.94%
Q2 2023
Q2Q % growth
-1.43
-7.52%
-1.460.032.23%
Q1 2023
Q2Q % growth
-1.33
13.07%
-1.390.064.39%
Q4 2022
Q2Q % growth
-1.19
20.67%
-1.270.086.39%
Q3 2022
Q2Q % growth
-1.32 -1.450.139.27%
Q2 2022
Q2Q % growth
-1.33
-14.66%
-0.96-0.37-38.72%
Q1 2022
Q2Q % growth
-1.53
-61.05%
-1.650.127.05%
Q4 2021
Q2Q % growth
-1.50
-89.87%
-1.570.074.64%
Q3 2021
Q2Q % growth
-1.32
-100.00%
-1.390.075.31%
Q2 2021
Q2Q % growth
-1.16
-87.10%
-1.190.032.56%
Q1 2021
Q2Q % growth
-0.95
-63.79%
-1.000.054.97%
Q4 2020
Q2Q % growth
-0.79
-61.22%
-0.890.1010.83%
Q3 2020
Q2Q % growth
-0.66
72.61%
-0.700.046.22%
Q2 2020
Q2Q % growth
-0.62 -0.660.045.76%
Q1 2020
Q2Q % growth
-0.58 -0.56-0.02-3.39%
Q4 2019
Q2Q % growth
-0.49 -0.44-0.05-11.07%
Q3 2019
Q2Q % growth
-2.41 -0.83-1.58-189.31%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
516K
1.38%
272.564K243.436K89.31%
Q2 2024
Q2Q % growth
1.254M
179.91%
55.399M-54.145M-97.74%
Q1 2024
Q2Q % growth
497K
-4.79%
774.568K-277.568K-35.84%
Q4 2023
Q2Q % growth
651K
75.95%
716.173K-65.173K-9.10%
Q3 2023
Q2Q % growth
509K
54.24%
829.036K-320.036K-38.60%
Q2 2023
Q2Q % growth
448K
21.08%
813.552K-365.552K-44.93%
Q1 2023
Q2Q % growth
522K 1.677M-1.155M-68.87%
Q4 2022
Q2Q % growth
370K 307.275K62.725K20.41%
Q3 2022
Q2Q % growth
330K 258.172K71.828K27.82%
Q2 2022
Q2Q % growth
370K 27.413M-27.043M-98.65%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4.09% -1.85% -8.75%
Revenue0% -10.49% -74.62% -69%